| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |